September 10th at 1:30 PM

NYC Chapter: September Healthcare Summit

New York

Ice Miller
1500 Broadway
Suite 2900
New York, New York, 10036

Time and Date

This event starts on September 10th at 1:30 PM.


Panel Topics:

  1. Private Equity Panel: Private Equity in Healthcare - Trends, Accelerated Growth, and Lessons Learned  
  2. Investment Banking Panel: Is There Still Value in Lower Middle Market Healthcare?
  3. Executive Panel: Innovation in Healthcare and How It Affects M&A Opportunities

1:30 PM – 2:00 PM: Registration  
2:00 PM – 3:00 PM: PE Panel   
3:00 PM – 4:00 PM: IB Panel   
4:00 PM – 5:00 PM: Executive Panel   
5:00 PM – 7:00 PM: Cocktail Reception 


PE Panel: Private Equity in Healthcare - Trends, Accelerated Growth, and Lessons Learned

In 2018, global private-equity backed healthcare deals rose almost 50% to $63.1 billion. 2019 deal volume shows there is no slowdown in sight. Healthcare has historically shown strong growth and superior historical returns but are there still good opportunities in the market? Is the growth in private-equity backed deals sustainable? Provider deals (physician groups, behavioral health, retail centers and home care) have been the leader domestically but we’ve also seen deal growth in non-traditional providers like clinical trial sites and contract research organizations as well as healthcare support services like revenue cycle and supply chain management. Our panelists will discuss healthcare deals they’ve done and share the healthcare sectors in which they see the most opportunity. We will also discuss reasons behind their healthcare sector focus and lessons learned from recent deal activity.

Taryn Stone, Partner at Ice Miller 

Scott Kauffman, Partner at Northlane Capital Partners  
Nicholas F. Ganias, CFA, Principal at Brookside Mezzanine Partners
Reid Petersen, Vice President at Avego Healthcare Capital

IB Panel: Is There Still Value in Lower Middle Market Healthcare?
Healthcare has been one of the hottest sectors for investment over the last several years, with deep-pocketed private equity firms and strategic buyers bidding aggressively against one another and driving valuations into the stratosphere. In 2009, private equity firms completed ~200 healthcare deals, and by 2016 this had tripled to more than 600 deals. With all this money chasing high quality assets, is it too late to get into the sector or are there still buying opportunities that can lead to compelling investment returns? Our panel of healthcare sector focused investment bankers will share why healthcare continues to be an attractive sector for investment and what they are seeing in today’s marketplace related to areas where there may still be some value-based buying opportunities vs. those subsectors that may be overheated. We will explore the current regulatory environment, the shift toward value-based care, technology’s impact on the sector, buyer behavior, valuations, buy-and-build strategies and the potential for corporate carve-outs, among other topics.

Ken Heuer, Principal at Kidd & Company

Lance Carr, Senior Vice President at Houlihan Lokey 
Richard Blann, Managing Director at Cantor Fitzgerald
Kenneth Benton, Vice President at Ziegler
David Blume, Managing Director at Edgemont Partners

Executive Panel: Innovation in Healthcare and How It Affects M&A Opportunities
Demographic and economic changes have fueled the expansion of healthcare as a proportion of U.S. GDP for decades, and U.S. personal healthcare spending is expected to rise at an average of 5.5% annually through 2026, increasing from 17.6% of GDP in 2017 to 19.7% by 2026, according to Centers for Medicare & Medicaid Services (CMS) estimates.Two major drivers of this trend are (i) demographic changes driving demand for services, as the much-expected impact of aging baby-boomers becomes apparent, and (ii) the proliferation of innovation disrupting the healthcare sector to meet demand from healthcare consumers and address resource scarcity issues.

The panel will discuss recent innovations in healthcare across a range of subsectors, how this causes disruption, and ultimately affects M&A opportunities. Topics which will be discussed include innovations impacting healthcare services, pharmaceuticals, and medical devices including digitalization, big data, artificial intelligence, telemedicine, immunotherapy, amongst others.

Mark Billings, Managing Director at CFGI

Dr. Chitra Dorai, Founder & CEO at Amicus Brain Innovations Inc.
Harris Hafeez, Managing Director & Member at Advanced PMR
Wendy DiCicco, Board Member at 
EyePoint Pharmaceuticals & Carmell Therapeutics 
Marc Duey, Founder/President/CEO at ProMetrics


  • Opus Connect Members: No Charge  
  • Non- Members (On or before September 5th): $395
  • Non-Members (On or after September 6th): $495

By Invitation Only

Opus Connect is a membership-based organization.
If you have any queries, please contact 
*Opus Connect adheres to a strict no cancellations, no refunds, no application of registration fees to future events policy.  
Qualified substitutions are accepted. To send a substitute, please notify 
**Opus Connect reserves the right to refuse entry to prospective attendees


1f04273f5ad585753f9e68868d0885d69b2ea83b medium
Ken Heuer
Kidd & Company, LLC.
F6d85c60fb4876513cca425fcf4da9dc7b6c793c medium
Mark Billings
Managing Director
E75bae2a1d10ecd3d0b0e7484e2f96cf3b7daa67 medium
Taryn Stone
Ice Miller LLP


0192926d59377abeb80e85215c98fd1ab2d58032 medium
David Blume
Edgemont Partners
Co-founder/ Managing Director
473fd5e6b7d45cf1506f7adfa72c7fb3bd020c71 medium
Dr. Chitra Dorai
Amicus Brain Innovations Inc.
Founder & CEO
91eb26125c36bfa822c1da175d9f392d8ce77f61 medium
Harris Hafeez
Advanced PMR
Managing Director & Member
E8fc3fe5a34b1fc96364b732861a18a70cf7b0c3 medium
Kenneth Benton
Vice President
A50a2048433edf921670a1b385fe21b6c3178da2 medium
Lance Carr
Houlihan Lokey
Senior Vice President
2b06375ec29180868389b2bd90df8bb3081d6cb5 medium
Marc Duey
Founder/ President/ CEO
15b3d483a121e4d429203f3e6eeb410fe87d883d medium
Nicholas Ganias
Brookside Mezzanine Partners
4b111957f062f56bb4b769849f571ae5e597d42f medium
Reid Petersen
Avego Healthcare Capital
Vice President
33c8f51da9040406643bdf839742fd34ca2b3747 medium
Richard Blann
Cantor Fitzgerald
Managing Director, Investment Banking Healthcare
050ff0c9b0b9e6c83ddfe1d017320acf09067a13 medium
Scott Kauffman
Northlane Capital Partners
Bd5fbc3a11766d0c7d12619c00efbb9ca3240d3d medium
Wendy DiCicco
EyePoint Pharmaceuticals/ Carmell Therapeutics
Board Member


September 10th
1:30 PM Afternoon Panels Registration
2:00 PM Private Equity Panel
3:00 PM Investment Banking Panel
4:00 PM Executive Panel
5:00 PM Cocktail Reception
7:00 PM End


Register for this event